Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Electron Transport Chain Deficiencies, Mitochondrial

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strahlendorf, J1
Box, C1
Attridge, J1
Diertien, J1
Finckbone, V1
Henne, WM1
Medina, MS1
Miles, R1
Oomman, S1
Schneider, M1
Singh, H1
Veliyaparambil, M1
Strahlendorf, H1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Electron Transport Chain Deficiencies, Mitochondrial

ArticleYear
AMPA-induced dark cell degeneration of cerebellar Purkinje neurons involves activation of caspases and apparent mitochondrial dysfunction.
    Brain research, 2003, Dec-24, Volume: 994, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Animals, Newborn; bcl-2-Associate

2003